(taken from the application) Cytokine-mediated pancreatic beta cell toxicity is likely to play an important role in the pathogenesis of Type 1 diabetes and islet transplantation rejection. The mechanisms by which cytokines induce damage in beta cells are starting to be elucidated, and free radical/lipid hydroperoxide formation appears to be an important factor. Our work has focused on the 12-lipoxygenase (12-LO) enzyme pathway that is found specifically in islet beta cells, but not alpha or delta cells. 12-LO is induced by cytokines and oxidant stress, and leads to the generation of lipid hydroperoxides in pancreatic beta cells. In addition, metabolites of the 12-LO pathway can act as intracellular signals that regulate the redox-sensitive transcription factor NF-kappa-B and also may be involved in programmed cell death. In this proposal, we will test the hypothesis that inhibition of the 12-LO pathway with a novel molecular tool called a ribozyme will protect pancreatic beta cells from cytokine-induced dysfunction and cytotoxicity. We will compare the efficiency of adenovirus (AdV) versus adeno-associated virus (AAV) in transferring a 12-LO ribozyme to pancreatic islets and beta cells. We will first test the efficacy of AdV and AAV vectors in transferring the reporter genes beta-galactosidase and placental alkaline phosphatase. We will then examine the effects of viral vector based delivery of the 12-LO ribozyme (12-LORz) and a catalytically inactive ribozyme (12-LOMRz) to islets and beta cells. In addition, porcine pancreatic islets will be treated with 12-LORz and 12-LOMRz and implanted into the kidney subcapsular space of streptozotocin-induced diabetic rats. Islets implanted will be compared for degree of acute graft rejection. As an alternative approach to understanding the effects of 12-LO inhibition on cytokine-induced islet cytotoxicity, we will utilize a 12-LO knockout mouse model. Islets will be purified from knockout mice and controls and compared fo sensitivity to cytokines and activation of stress-induced kinases. Finally, we will overexpress 12-LO in MIN6 cells with a tetracycline-inducible promoter in order to determine the effects of excess 12-LO products on pancreatic beta cel function and cytotoxicity. The data generated in this grant will help to determine whether AAV can efficiently transfer genes to pancreatic islets and provide evidence supporting the role for the 12-LO pathway in immune mediated islet cell destruction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK055240-01
Application #
2760278
Study Section
Special Emphasis Panel (ZDK1-GRB-B (O1))
Program Officer
Harmon, Joan T
Project Start
1998-09-30
Project End
1999-07-31
Budget Start
1998-09-30
Budget End
1999-07-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Galkina, Elena V; Butcher, Matthew; Keller, Susanna R et al. (2012) Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arterioscler Thromb Vasc Biol 32:247-56
Weaver, Jessica R; Holman, Theodore R; Imai, Yumi et al. (2012) Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Mol Cell Endocrinol 358:88-95
Morris, Margaret A; McDuffie, Marcia; Nadler, Jerry L et al. (2011) Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. Autoimmunity 44:115-28
Kenyon, Victor; Rai, Ganesha; Jadhav, Ajit et al. (2011) Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase. J Med Chem 54:5485-97
Dobrian, Anca D; Lieb, David C; Cole, Banumathi K et al. (2011) Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 50:115-31
Green-Mitchell, Shamina M; Cazares, Lisa H; Semmes, O John et al. (2011) On-tissue identification of insulin: in situ reduction coupled with mass spectrometry imaging. Proteomics Clin Appl 5:448-53
Dobrian, A D; Ma, Q; Lindsay, J W et al. (2011) Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. Am J Physiol Endocrinol Metab 300:E410-21
Chakrabarti, Swarup K; Wen, Yeshao; Dobrian, Anca D et al. (2011) Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. Am J Physiol Endocrinol Metab 300:E175-87
Maier, Bernhard; Ogihara, Takeshi; Trace, Anthony P et al. (2010) The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 120:2156-70
Fu, Zhuo; Zhang, Wen; Zhen, Wei et al. (2010) Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151:3026-37

Showing the most recent 10 out of 37 publications